Related references
Note: Only part of the references are listed.Epidemiological research - cancer registry data. Survival time analysis - comparison of national and international results
Hermann Brenner et al.
ONKOLOGE (2017)
Quality Improvement in the Era of Big Data
Michael J. Hassett
JOURNAL OF CLINICAL ONCOLOGY (2017)
Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement
Kala Visvanathan et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study
Kim A. Reiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
Girish S. Kulkarni et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Future cancer research priorities in the USA: a Lancet Oncology Commission
Elizabeth M. Jaffee et al.
LANCET ONCOLOGY (2017)
Accelerating development of scientific evidence for medical products within the existing US regulatory framework
Rachel E. Sherman et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Evidence for Health Decision Making - Beyond Randomized, Controlled Trials
Thomas R. Frieden
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Importance of the cancer registry in health care research. Registry studies vs. clinical studies using the example of colon cancer
Monika Klinkhammer-Schalke et al.
ONKOLOGE (2017)
Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making
Marc L. Berger et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies
Angela Spelsberg et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies
Angela Spelsberg et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer
Larissa A. Meyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Relevance of randomised controlled trials in oncology
Ian F. Tannock et al.
LANCET ONCOLOGY (2016)
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study
Marissa C. van Maaren et al.
LANCET ONCOLOGY (2016)
Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database
Daniel P. Nussbaum et al.
LANCET ONCOLOGY (2016)
Patient-reported outcomes in the evaluation of toxicity of anticancer treatments
Massimo Di Maio et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Predicting the Future - Big Data, Machine Learning, and Clinical Medicine
Ziad Obermeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Transforming Evidence Generation to Support Health and Health Care Decisions
Robert M. Califf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Real-World Evidence - What Is It and What Can It Tell Us?
Rachel E. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Using data from registries like the TraumaRegister DGU((R)) for effectiveness evaluations
Rolf Lefering
ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN (2016)
Is the age of causality over?
Gerd Antes
ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN (2016)
Make sense of health data
Julian H. Elliott et al.
NATURE (2015)
Patient-reported outcomes as end points and outcome indicators in solid tumours
Angeles A. Secord et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
C. M. Booth et al.
BRITISH JOURNAL OF CANCER (2014)
Learning from Big Health Care Data
Sebastian Schneeweiss
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A 1-year cross-sectional analysis of non-interventional post-marketing study protocols submitted to the German Federal Institute for Drugs and Medical Devices (BfArM)
Beatrice K. J. G. von Jeinsen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Sarah C. Darby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Treating Individuals 1 - External validity of randomised controlled trials: To whom do the results of this trial apply?'
PM Rothwell
LANCET (2005)
Share Paper
